Golden State Wealth Management, LLC Oramed Pharmaceuticals Inc. Transaction History
Golden State Wealth Management, LLC
- $673 Billion
- Q1 2025
A detailed history of Golden State Wealth Management, LLC transactions in Oramed Pharmaceuticals Inc. stock. As of the latest transaction made, Golden State Wealth Management, LLC holds 303 shares of ORMP stock, worth $705. This represents 0.0% of its overall portfolio holdings.
Number of Shares
303
Previous 606
50.0%
Holding current value
$705
Previous $1,000
64700.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ORMP
# of Institutions
64Shares Held
8.1MCall Options Held
17.4KPut Options Held
19.5K-
Bml Capital Management, LLC Zionsville, IN2.64MShares$6.16 Million3.97% of portfolio
-
Murchinson Ltd. Toronto, A61.75MShares$4.08 Million2.03% of portfolio
-
Boothbay Fund Management, LLC New York, NY845KShares$1.97 Million0.06% of portfolio
-
Morgan Jess S & CO Inc366KShares$853,7142.07% of portfolio
-
Rathbones Group PLC Liverpool, X0290KShares$675,2400.0% of portfolio
About ORAMED PHARMACEUTICALS INC.
- Ticker ORMP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,100
- Market Cap $90.5M
- Description
- Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...